KCT0005532招募中未知
Multi-center, Investigator-initiated trial for evaluating the efficacy and safety of D+storm stent
Ajou University Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 19?(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •1) Adult over 19 years old
- •2) Patients treated with D+storm sirolimus elutating coronary stent
- •3) Patients who agree to a Protocol and a clinical follow-up survey plan and who have agreed in writing to a patient consent form approved by the clinical Institutional Review Board of each research institute.
排除标准
- •1) Patients treated with drug elution stents other than D+ storm
- •2) Patients with a life expectancy of less than a year
- •3) A psychogenic shock patient
- •4) Patients with a left ventricular ejection fraction of less than 30%
- •5) A woman of a possible pregnancy age who plans to conceive during this study.
- •6) Patients who are judged to be inappropriate to participate in the study by other investigator
- •7) Subjects who are scheduled to undergo surgery that requires the discontinuation of antiplatelet drugs within 12 months of registration.
研究者
相似试验
招募中
不适用
Multi-hospital, exploratory clinical trial for evaluating the efficacy and safety of edema relief and leg pain reduction effect in the treatment using Intermittent pneumatic Compression for patients with edema pain in daily lifeKCT0004562Presbyterian Medical Center5
已完成
2 期
Evaluation of Vascular Electrical Stimulation Therapy on Vaso-Occlusive crises in sickle cell patients.PACTR201907740118144Diavein SAS30
已完成
不适用
A multi-center, retrospective pivotal trial to evaluate the efficacy of artificial intelligence-based pulmonary nodule detection software ‘VUNO Med – Lung CAD’ in thoracic CTDiseases of th respiratory systemKCT0005065Vuno855
进行中（未招募）
1 期
An open-label, multicenter, follow-up trial to evaluate long-term safety and efficacy ofucb 34714 used as adjunctive treatment at a flexible dose up to a maximum of 150 mg/day in subjects aged 16 years or older suffering from partial onset seizuresEpilepsy - refractory Partial Onset SeizureMedDRA version: 8.0Level: LLTClassification code 10061334EUCTR2004-002140-10-ESCB S.A. Pharma Sector1,000
进行中（未招募）
1 期
An open-label, multicenter, follow-up trial to evaluate long-term safety and efficacy of brivaracetam (ucb 34714) used as adjunctive treatment at a flexible dose up to a maximum of 150 mg/day in subjects aged 16 years or older suffering from epilepsy.EpilepsyEUCTR2004-002140-10-GBCB S.A.853